Company Insight

Breast cancer treatment: Nitinol’s solution for effective biopsy markers

Nitinol, the shape-memory alloy comprised of nickel and titanium, has been causing a stir in the medical technology industry for some years. How can its unique properties change the way that we identify biopsy sites?

Following a biopsy where tissue samples have been removed, doctors may use a tool to leave a clip made of surgical-grade material. This marker will be visible on a mammogram, and it is vital for doctors to be able to identify the exact biopsy site, especially if the patient is undergoing chemotherapy which may change the size and shape of the area.

Some challenges associated with typical biopsy markers include that when the marker is pushed out of the applicator, it does not have the opportunity to fix into the tissue. While there are biopsy markers on the market that are designed to overcome this, it can take up to 24 hours for the marker to attach. This means that there is a risk that the marker migrates after the procedure, so doctors do not see an accurate biopsy site location in the mammograms that follow.

Further challenges occur if a patient has undergone more than one biopsy. In this scenario, it is likely that a doctor will use differently shaped markers in order to distinguish between the biopsy sites. However, the majority of markers are 2D, meaning that they can look vastly different depending on the angle they are being viewed from. An “X” shaped marker, for example, may look like a straight line if it is observed from the side.

Nitinol and shape-memory innovation

Endosmart,a Germany-based company acquired by Alleima last year, is trailblazing the use of nitinol in medical devices. Its product offerings include surgical instruments and components, such as kidney stone retrieval baskets and snares, as well as breast cancer tumour markers.

Nitinol’s unique shape memory properties means that it can easily overcome a number of challenges associated with biopsy markers. Firstly, nitinol can be compressed and loaded into an applicator so that when it is pushed out, it immediately returns to its original shape. This means that it can immediately fix itself into the tissue, removing the risk of the marker migrating.

Endosmart is also manufacturing markers in a range of specific shapes so that doctors can leave different markers when carrying out multiple biopsies. Unlike most markers on the market, Endosmart is developing 3D marking systems that will be easily identifiable from any angle.

Alleima, a medical-wire component manufacturer that specialise in customised sensor wire and the nitinol experts from Endosmart are now together looking to combine their expertise and accelerate the use of nitinol in the medical industry where it can be a major benefit to both patients and healthcare providers alike.

Meet the Alleima team at the EPHJ tradeshow 6-9 June.

Contact information

Alleima Advance Materials
1 Commerce Blvd.,
Palm Coast, FL, 32164,
United States

Tel: +1 386 445-2000
Fax: +1 386 447-5113
Email:ms.spc@alleima.com

Alleima Tucson
2424 East Aragon Rd
Tucson, AZ 85756
United States

Tel: +1 520 495 5927

Alleima Zug
Oberallmendstrasse 20a
CH-6300 Zug

Tel: +41 41 761 63 55
Email: sales@alleima.com

Alleima St Imier
Rue de Beau Site 8
CH-2610 Saint-Imier

Tel: +41 32 942 39 20
Email:info@alleima.com

Web:www.alleima.com/exera

Go to article: Home | AI is reimagining imaging, but how far can we go today?Go to article: Editor's letterGo to article: ContentsGo to article: Alleima Company InsightGo to article: AlleimaGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Apple RubberGo to article: mdi ConsultantsGo to article: In DepthGo to article: AI is reimagining imaging, but how far can we go today? Go to article: Understanding updates on medical device labelling Go to article: Mass spectrometry and photometry for rAAV vector characterisation   Go to article: More than just meetings? Zoom scales ambitions in telehealth Go to article: Breathing easy: How digital inhalers are changing asthma treatment  Go to article: The cost of companion diagnostics in oncology Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: ESG moves up the agendaGo to article: ESG is the most important theme of this decadeGo to article: A timeline of corporate ESGGo to article: The most pressing ESG concerns for the medical device industryGo to article: Key trends impacting ESG performance in the medical device sectorGo to article: Latest news: ESG in medical devicesGo to article: Q&A with GlobalData thematic analystGo to article: Sustainable supply chains: Clinical trials in a new era of limited resources  Go to article: GlobalData highlights the need for ESG commitment by medical device companies Go to article: Leading medical companies in the ESG theme Go to article: Environmental sustainability innovation: leading companies in biomedical 3D prinGo to article: Deal activity related to ESG in the medical industry since 2020Go to article: ESG hiring trends in the global medical industry since 2020 Go to article: ESG patent applications in the global medical industry since 2020Go to article: Mentions of ESG in medical industry company filings since 2020Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored supplementsGo to article: WatlowGo to article: Mimotopes Company InsightGo to article: ListingsGo to article: EventsGo to article: Get ready for the Medical Device Network Excellence Awards Go to article: Buyer's GuidesGo to article: Next issue